PACS

PACS GroupA

NYSE / Health Care Equipment & Services

At close

2026-06-02

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

30%

Probability

Target price

$52.00

+40.9% vs current

Most likely

Base case

50%

Probability

Target price

$46.40

+25.7% vs current

B-

Bear case

20%

Probability

Target price

$30.00

-18.7% vs current

AI sentiment snapshot

Latest data as of 2026-05-29

AI commentary

Sentiment is constructive but not clean: the Q1 print triggered a roughly 23.7% premarket jump, and later analyst follow-through was positive, but the market has already repriced much of the beat. Coverage remains thin, the peer set is loose, and the unresolved legal/control overhang keeps this in monitoring territory rather than a clean bullish reset.

RankAlpha Sentiment Codex - 2026-05-29

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-05-11eventRaised FY26 EBITDA guidance plus buyback supportMedium impact

Management lifted full-year 2026 adjusted EBITDA guidance to $605M-$625M from $555M-$575M, reaffirmed revenue guidance of $5.65B-$5.75B, and authorized a $250M share repurchase program, creating a cleaner capital-return story. [#8-K-2026-05-11]

2026-05-12eventQ1 beat already drove a sharp rerateMedium impact

First-quarter 2026 revenue rose 11.2% to $1.42B, adjusted EBITDA rose 74.6% to $170.4M, and net income increased to $80.7M; the release also triggered a roughly 23.7% premarket jump to $37.97, so a lot of the immediate surprise has already been absorbed. [#8-K-2026-05-11]

2026-12-31catalystOccupancy and maturity gains can sustain compoundingHigh impact

Same-store SNF revenue increased 8.0%, occupancy improved to 90.9%, 78.4% of the skilled-nursing portfolio earned 4- or 5-star CMS quality ratings, and liquidity stayed high at $795.1M with net leverage near 0.1x, supporting a longer-duration operating and valuation recovery thesis. [#8-K-2026-05-11]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-05-29 • Updated nightlySource: Internal modelMethodology